Is Bloom Energy The Best Stock to Buy Now?
Shares of energy startup Bloom Energy (NYSE:BE) have advanced by…
Sell
38
SYBX Quote, Financials, Valuation and Earnings
Last price:
$1.20
Seasonality move
:
23.09%
Day range:
$1.14 - $1.28
52-week range:
$0.90 - $1.96
Dividend yield:
0%
P/E ratio:
11.67x
P/S ratio:
5.38x
P/B ratio:
1.36x
Volume:
35.6K
Avg. volume:
60.8K
1-year change:
-12.52%
Market cap:
$14M
Revenue:
$8K
EPS (TTM):
-$0.27
Analysts' Opinion
-
Consensus RatingNo consensus rating exists at this time due to lack of analyst coverage.
-
Price Target DownsideNo price target exists because of limited analyst coverage.
-
Price Target UpsideSimilarly, at this time, analysts have not provided a price target so downside risk can't be assessed accurately at this time.
Fair Value
-
According to the consensus of 0 analysts, Synlogic, Inc. has -16.67% downside to fair value with a price target of -- per share.
SYBX vs. S&P 500
-
Over the past 5 trading days, Synlogic, Inc. has overperformed the S&P 500 by 8% suggesting its relative strength compared to the major market average is strong at this time.
Share Buyback
-
Synlogic, Inc. does have a share repurchase program in place at this time. The scale of a buyback program can materially affect share price and usually results in a higher earnings per share, all else being equal, when the share count drops.
Revenue Growth
-
Synlogic, Inc. revenues have been falling on a year-over-year basis for 5 quarters in a row. In the most recent quarter Synlogic, Inc. reported revenues of --.
Earnings Growth
-
Synlogic, Inc. earnings have been falling on a year-over-year basis for 2 quarters in a row. In the most recent quarter Synlogic, Inc. reported earnings per share of -$0.19.
Enterprise value:
-1.6M
EV / Invested capital:
--
Price / LTM sales:
5.38x
EV / EBIT:
-2.73x
EV / Revenue:
-0.28x
PEG ratio (5yr expected):
--
EV / Free cash flow:
0.39x
Price / Operating cash flow:
--
Enterprise value / EBITDA:
-2.73x
Gross Profit (TTM):
--
Return On Assets:
-17.45%
Net Income Margin (TTM):
-2284.68%
Return On Equity:
-26.08%
Return On Invested Capital:
-26.08%
Operating Margin:
-131950%
| Trailing 12 Months | Fiscal Quarters | |||||
|---|---|---|---|---|---|---|
| Period Ending | 2023-09-30 | 2024-09-30 | 2025-09-30 | 2024-09-30 | 2025-09-30 | |
| Income Statement | ||||||
| Revenue | $708K | $2.8M | -- | -- | -- | |
| Gross Profit | -$4.7M | $211K | -- | -- | -- | |
| Operating Income | -$61.8M | -$25M | -$3.9M | -$452K | -$826K | |
| EBITDA | -$56.4M | -$22.5M | -$3.9M | -$452K | -$826K | |
| Diluted EPS | -$12.72 | -$3.58 | -$0.27 | -$0.01 | -$0.19 | |
| Period Ending | 2021-09-30 | 2022-09-30 | 2023-09-30 | 2024-09-30 | 2025-09-30 | |
|---|---|---|---|---|---|---|
| Balance Sheet | ||||||
| Current Assets | $156.6M | $97.5M | $37.8M | $20.7M | $16.5M | |
| Total Assets | $190.5M | $128.2M | $66.3M | $20.8M | $16.6M | |
| Current Liabilities | $10.6M | $11.6M | $9.1M | $7.6M | $6.2M | |
| Total Liabilities | $29M | $27.8M | $22.9M | $7.6M | $6.2M | |
| Total Equity | $161.6M | $100.4M | $43.4M | $13.1M | $10.3M | |
| Total Debt | $18.2M | $16.2M | $13.7M | -- | -- | |
| Trailing 12 Months | Fiscal Quarters | |||||
|---|---|---|---|---|---|---|
| Period Ending | 2023-09-30 | 2024-09-30 | 2025-09-30 | 2024-09-30 | 2025-09-30 | |
| Cash Flow Statement | ||||||
| Cash Flow Operations | -$58.5M | -$36.6M | -$4M | -$649K | -$1.4M | |
| Cash From Investing | $68.3M | $10.7M | $197K | $72K | -- | |
| Cash From Financing | -$865K | $19.7M | $9K | -- | -- | |
| Free Cash Flow | -$58.7M | -$36.7M | -$4M | -$649K | -$1.4M | |
SYBX
Sector
Market Cap
$14M
$27.9M
Price % of 52-Week High
61.22%
51.04%
Dividend Yield
0%
0%
Shareholder Yield
-0.05%
-1.49%
1-Year Price Total Return
-12.52%
-16.66%
Beta (5-Year)
0.361
0.516
Dividend yield:
0%
Annualized payout:
$0.00
Payout ratio:
--
Growth streak:
0 years
Technicals
8-day SMA
Buy
Level
$1.11
200-day SMA
Sell
Level
$1.38
Bollinger Bands (100)
Sell
Level
1.33 - 1.73
Chaikin Money Flow
Buy
Level
16.5K
20-day SMA
Sell
Level
$1.26
Relative Strength Index (RSI14)
Sell
Level
41.45
ADX Line
Buy
Level
19.93
Williams %R
Neutral
Level
-54.7619
50-day SMA
Sell
Level
$1.52
MACD (12, 26)
Buy
Level
0.22
25-day Aroon Oscillator
Sell
Level
-52
On Balance Volume
Neutral
Level
164.4K
Financial Scores
Sell
Altman Z-Score
(Annual)
Level (-31.6551)
Sell
CA Score
(Annual)
Level (-2.0616)
--
Beneish M-Score
(Annual)
Level (--)
Buy
Momentum Score
Level (8)
Sell
Ohlson Score
Level (8.2185)
Sell
Piotroski F Score
(Annual)
Level (3)
Sell
Quality Ratio Score
Level (2)
Sell
Fundamental Score
Level (2)
Revenue Forecast
Earnings per Share Forecast
Company Profile
Synlogic, Inc. is a biopharmaceutical company which engages in the discovery and development of synthetic biotic medicines. It focuses on phenylketonuria, enteric hyperoxaluria, immuno-oncology solid tumors, inflammatory bowel disease, and vaccines and other inflammatory programs. The company was founded by James J. Collins and Timothy K. Lu on December 20, 2007 and is headquartered in Cambridge, MA.
Stock Forecast FAQ
In the current month, SYBX has received 0 Buy ratings 0 Hold ratings, and 0 Sell ratings. The SYBX average analyst price target in the past 3 months is --.
-
Where Will Synlogic, Inc. Stock Be In 1 Year?
According to analysts, the consensus estimate is that Synlogic, Inc. share price will drop to -- per share over the next 12 months.
-
What Do Analysts Say About Synlogic, Inc.?
Analysts are divided on their view about Synlogic, Inc. share price and where it will be in the next 12 months. The majority of analysts rate the stock a Buy. However, a smaller subset of analysts suggest that Synlogic, Inc. is a Sell and believe this share price will rise from its current level to --.
-
What Is Synlogic, Inc.'s Price Target?
The price target for Synlogic, Inc. over the next 1-year time period is forecast to be -- according to 0 Wall Street analysts, 0 of them rate the stock a Buy, 0 rate the stock a Sell, and 0 analysts rate the stock a Hold.
-
Is SYBX A Buy, Sell Or Hold?
According to Wall Street analysts, the consensus rating for Synlogic, Inc. is a --. 0 of 0 analysts rate the stock a -- at this time.
-
How Can I Buy Shares Of SYBX?
You can purchase shares of Synlogic, Inc. via an online brokerage firm such as TD Ameritrade.com, thinkorswim.com, e-trade.com, or Schwab.com. Many other digital online brokerages exist such as RobinHood and Webull where you can purchase Synlogic, Inc. shares.
-
What Is The Synlogic, Inc. Share Price Today?
Synlogic, Inc. was last trading at $1.20 per share. This represents the most recent stock quote for Synlogic, Inc.. Yesterday, Synlogic, Inc. closed at $1.20 per share.
-
How To Buy Synlogic, Inc. Stock Online?
In order to purchase Synlogic, Inc. stock online, open a brokerage account, deposit funds into the account, and select an order type to purchase shares whether it be market or limit.
Get SYBX Stock Alert
Signup to receive the latest stock alerts
Financial Ratios
SYBX
Sector
P/E ratio
11.67x
23.85x
PEG ratio
--
-0.01x
P/B ratio
1.36x
1.81x
Price / LTM sales
5.38x
1.58x
Growth Metrics
SYBX
Sector
Revenue growth
-95.4%
4.62%
Earnings growth
-1845.83%
10.5%
Revenue (5-year growth)
-67.55%
6.5%
Earnings forecast
-$0.16
-$0.21
Profitability
SYBX
Sector
Profitability FY 2024
-$1.3M
$3.6M
Return on invested capital
-26.08%
-31.87%
Return on assets
-17.45%
-28.18%
Return on equity
-26.08%
-37.63%
Earnings Date
Last Earnings Date
May
9
Next Earnings Date
Dec
22
Estimated Next Earnings Date
Mar
23
Balance Sheet
SYBX
Sector
Total cash
$15.6M
$26.4M
Short term investments
--
$25.7M
Total assets
$19.8M
$76.9M
Long term debt
--
$3.4M
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
Popular
Is Berkshire Hathaway Stock Undervalued?
Berkshire Hathaway (NYSE:BRK.A,BRK.B) has undershot the market this year, returning…
Is Oracle Stock Undervalued?
Shares of Oracle (NYSE:ORCL) rocketed higher earlier this year when…
Stock Ideas
Buy
54
Is NVDA Stock a Buy?
Market Cap: $4.4T
P/E Ratio: 62x
Buy
53
Is AAPL Stock a Buy?
Market Cap: $4T
P/E Ratio: 37x
Buy
57
Is GOOG Stock a Buy?
Market Cap: $3.7T
P/E Ratio: 38x
Alerts
Sell
1
LW alert for Dec 20
Lamb Weston Holdings, Inc. [LW] is down 25.96% over the past day.
Buy
54
BMRN alert for Dec 20
BioMarin Pharmaceutical, Inc. [BMRN] is up 17.79% over the past day.
Buy
82
RKLB alert for Dec 20
Rocket Lab Corp. [RKLB] is up 17.72% over the past day.
THE #1 STOCK ANALYSIS TOOL
TO MAKE SMARTER BUY AND SELL DECISIONS
Show me the best stock
